Web10 sep. 2024 · Aim: The relationship between hyperuricemia and polymorphisms of transporter genes in coronary artery disease (CAD) patients in China remains unclear. Materials & methods: A total of 258 hyperuricemia patients with CAD and 242 control patients with CAD were recruited in this case–control study. Web28 feb. 2024 · The American Geriatrics Society recommends a goal a1c of 7.5-8% in older patients with moderate comorbidities and life expectancy less than 10 years; 7 the American Diabetes Association recommends a more relaxed goal of 8-8.5% for older patients with complex medical issues. 1 These recommendations are supported by …
Is Allopurinol Safe in Hyperuricemia with History of …
Web12 mrt. 2024 · Hyperuricemia has been associated with several cardiovascular risk factors and is a well-known predictor of kidney disease. In vitro studies as well as animal models highlighted a role for uric acid in the development and progression of haemodynamic and tissue damage at the renal level leading to glomerular and tubulointerstitial abnormalities. WebEffects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery disease Effects of genetic and nongenetic factors on hyperuricemia in … landa north dakota
Prognostic Significance of Uric Acid in Patients with ... - PubMed
Web28 dec. 2024 · Evidence suggests that hyperuricemia and gout are independently linked to an increased risk of coronary artery disease (CAD), heart failure (HF), and … Web7 mrt. 2024 · Hyperuricemia and hypouricemia increased mortality in both males and females. 27 But Luo's study failed to prove a U-shaped relationship between SUA and mortality in patients with CKD, which is similar with this study population patients with RAS. 33 So, the arising question is why survival curve in RAS population was different from … Web18 dec. 2015 · Objectives An increased risk of mortality in patients with hyperuricemia has been reported. We examined (1) the risk of all-cause and cardiovascular disease (CVD) mortality in untreated hyperuricemic patients who did not receive urate-lowering therapy (ULT), and (2) the impact of ULT on mortality risk in patients with hyperuricemia. … lan dan man